TGen Gets Funding for Inflammatory Breast Cancer Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute has received a $50,000 award to conduct DNA analysis studies focused on identifying the genetic origins of inflammatory breast cancer (IBC).

The funding from the Inflammatory Breast Cancer Foundation (IBCRF) will support efforts to analyze samples from IBC tumors for genetic similarities that could reveal a therapeutic vulnerability, TGen said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.